144 related articles for article (PubMed ID: 19398123)
1. Murine strain differences in hemostasis and thrombosis and tissue factor pathway inhibitor.
White TA; Pan S; Witt TA; Simari RD
Thromb Res; 2010 Jan; 125(1):84-9. PubMed ID: 19398123
[TBL] [Abstract][Full Text] [Related]
2. The effect of vascular smooth muscle cell-targeted expression of tissue factor pathway inhibitor in a murine model of arterial thrombosis.
Pan S; Kleppe LS; Witt TA; Mueske CS; Simari RD
Thromb Haemost; 2004 Sep; 92(3):495-502. PubMed ID: 15351845
[TBL] [Abstract][Full Text] [Related]
3. A balance between tissue factor and tissue factor pathway inhibitor is required for embryonic development and hemostasis in adult mice.
Pedersen B; Holscher T; Sato Y; Pawlinski R; Mackman N
Blood; 2005 Apr; 105(7):2777-82. PubMed ID: 15598816
[TBL] [Abstract][Full Text] [Related]
4. Endothelial-derived tissue factor pathway inhibitor regulates arterial thrombosis but is not required for development or hemostasis.
White TA; Johnson T; Zarzhevsky N; Tom C; Delacroix S; Holroyd EW; Maroney SA; Singh R; Pan S; Fay WP; van Deursen J; Mast AE; Sandhu GS; Simari RD
Blood; 2010 Sep; 116(10):1787-94. PubMed ID: 20516367
[TBL] [Abstract][Full Text] [Related]
5. Re-evaluation of mouse tissue factor pathway inhibitor and comparison of mouse and human tissue factor pathway inhibitor physiology.
Girard TJ; Grunz K; Lasky NM; Malone JP; Broze GJ
J Thromb Haemost; 2018 Nov; 16(11):2246-2257. PubMed ID: 30194803
[TBL] [Abstract][Full Text] [Related]
6. Endogenous tissue factor pathway inhibitor in vascular smooth muscle cells inhibits arterial thrombosis.
Yang J; Jin K; Xiao J; Ma J; Ma D
Front Med; 2017 Sep; 11(3):403-409. PubMed ID: 28550640
[TBL] [Abstract][Full Text] [Related]
7. Murine hematopoietic cell tissue factor pathway inhibitor limits thrombus growth.
Maroney SA; Cooley BC; Ferrel JP; Bonesho CE; Mast AE
Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):821-6. PubMed ID: 21233452
[TBL] [Abstract][Full Text] [Related]
8. Genetic background determines response to hemostasis and thrombosis.
Hoover-Plow J; Shchurin A; Hart E; Sha J; Hill AE; Singer JB; Nadeau JH
BMC Blood Disord; 2006 Oct; 6():6. PubMed ID: 17022820
[TBL] [Abstract][Full Text] [Related]
9. Role for tissue factor pathway in murine model of vascular remodeling.
Singh R; Pan S; Mueske CS; Witt T; Kleppe LS; Peterson TE; Slobodova A; Chang JY; Caplice NM; Simari RD
Circ Res; 2001 Jul; 89(1):71-6. PubMed ID: 11440980
[TBL] [Abstract][Full Text] [Related]
10. Presence of tissue factor pathway inhibitor in human atherosclerotic plaques is associated with reduced tissue factor activity.
Caplice NM; Mueske CS; Kleppe LS; Simari RD
Circulation; 1998 Sep; 98(11):1051-7. PubMed ID: 9736590
[TBL] [Abstract][Full Text] [Related]
11. Defective thrombus formation in mice lacking endogenous factor VII activating protease (FSAP).
Subramaniam S; Thielmann I; Morowski M; Pragst I; Sandset PM; Nieswandt B; Etscheid M; Kanse SM
Thromb Haemost; 2015 Apr; 113(4):870-80. PubMed ID: 25427855
[TBL] [Abstract][Full Text] [Related]
12. Dyslipidemia shifts the tissue factor/tissue factor pathway inhibitor balance toward increased thrombogenicity in atherosclerotic plaques: evidence for a corrective effect of statins.
Zawadzki C; Susen S; Richard F; Haulon S; Corseaux D; Jeanpierre E; Vincentelli A; Lucas C; Torpier G; Martin A; Van Belle E; Staels B; Jude B
Atherosclerosis; 2007 Dec; 195(2):e117-25. PubMed ID: 17196206
[TBL] [Abstract][Full Text] [Related]
13. Platelet-derived VWF is not essential for normal thrombosis and hemostasis but fosters ischemic stroke injury in mice.
Verhenne S; Denorme F; Libbrecht S; Vandenbulcke A; Pareyn I; Deckmyn H; Lambrecht A; Nieswandt B; Kleinschnitz C; Vanhoorelbeke K; De Meyer SF
Blood; 2015 Oct; 126(14):1715-22. PubMed ID: 26209660
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of Panx1 channels decreases hemostasis and thrombosis in vivo.
Molica F; Meens MJ; Pelli G; Hautefort A; Emre Y; Imhof BA; Fontana P; Scemes E; Morel S; Kwak BR
Thromb Res; 2019 Nov; 183():56-62. PubMed ID: 31669824
[TBL] [Abstract][Full Text] [Related]
15. Extrinsic blood coagulation pathway and risk factors for thrombotic events in patients with essential thrombocythemia.
Stankowska K; Gadomska G; Boinska J; Michalska M; Bartoszewska-Kubiak A; Rość D
Pol Arch Med Wewn; 2016 May; 126(5):340-6. PubMed ID: 27243342
[TBL] [Abstract][Full Text] [Related]
16. Deficiency of tissue factor pathway inhibitor promotes atherosclerosis and thrombosis in mice.
Westrick RJ; Bodary PF; Xu Z; Shen YC; Broze GJ; Eitzman DT
Circulation; 2001 Jun; 103(25):3044-6. PubMed ID: 11425765
[TBL] [Abstract][Full Text] [Related]
17. Post-transcriptional, post-translational and pharmacological regulation of tissue factor pathway inhibitor.
Subramaniam S; Kanse SM; Kothari H; Reinhardt C; Fletcher C
Blood Coagul Fibrinolysis; 2018 Dec; 29(8):668-682. PubMed ID: 30439766
[TBL] [Abstract][Full Text] [Related]
18. Tissue factor, tissue pathway factor inhibitor and risk factors of atherosclerosis in patients with chronic limbs ischemia: preliminary study.
Gosk-Bierska I; Wysokin Ski W; Karnicki K; Adamiec R
Int Angiol; 2008 Aug; 27(4):296-301. PubMed ID: 18677291
[TBL] [Abstract][Full Text] [Related]
19. Hemostatic effect of a monoclonal antibody mAb 2021 blocking the interaction between FXa and TFPI in a rabbit hemophilia model.
Hilden I; Lauritzen B; Sørensen BB; Clausen JT; Jespersgaard C; Krogh BO; Bowler AN; Breinholt J; Gruhler A; Svensson LA; Petersen HH; Petersen LC; Balling KW; Hansen L; Hermit MB; Egebjerg T; Friederichsen B; Ezban M; Bjørn SE
Blood; 2012 Jun; 119(24):5871-8. PubMed ID: 22563084
[TBL] [Abstract][Full Text] [Related]
20. EPAS1/HIF-2 alpha-mediated downregulation of tissue factor pathway inhibitor leads to a pro-thrombotic potential in endothelial cells.
Stavik B; Espada S; Cui XY; Iversen N; Holm S; Mowinkel MC; Halvorsen B; Skretting G; Sandset PM
Biochim Biophys Acta; 2016 Apr; 1862(4):670-678. PubMed ID: 26826018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
